FY2017 EPS Estimates for Masimo Corporation Boosted by Analyst (NASDAQ:MASI)
Masimo Corporation (NASDAQ:MASI) – Stock analysts at Wedbush increased their FY2017 earnings estimates for Masimo Corporation in a research note issued to investors on Thursday. Wedbush analyst Levy. T now anticipates that the medical equipment provider will post earnings of $2.80 per share for the year, up from their prior estimate of $2.65. Wedbush has a “Outperform” rating and a $112.00 price target on the stock. Wedbush also issued estimates for Masimo Corporation’s FY2018 earnings at $2.74 EPS and FY2019 earnings at $3.24 EPS.
Other analysts also recently issued research reports about the stock. Stifel Nicolaus started coverage on shares of Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 target price for the company. Roth Capital lifted their target price on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. BidaskClub upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Zacks Investment Research downgraded shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a report on Thursday, May 11th. Six research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Masimo Corporation currently has a consensus rating of “Hold” and an average target price of $87.50.
Shares of Masimo Corporation (MASI) opened at 85.29 on Friday. The company has a 50 day moving average price of $93.60 and a 200-day moving average price of $89.40. Masimo Corporation has a one year low of $52.07 and a one year high of $104.71. The stock has a market cap of $4.43 billion, a price-to-earnings ratio of 13.98 and a beta of 0.80.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.12. The firm had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. Masimo Corporation’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.57 earnings per share.
A number of institutional investors have recently modified their holdings of the stock. Federated Investors Inc. PA boosted its position in shares of Masimo Corporation by 273.4% in the second quarter. Federated Investors Inc. PA now owns 105,366 shares of the medical equipment provider’s stock valued at $9,607,000 after buying an additional 77,148 shares in the last quarter. Fortaleza Asset Management Inc. acquired a new position in shares of Masimo Corporation during the second quarter valued at approximately $106,000. Jennison Associates LLC boosted its position in shares of Masimo Corporation by 111.3% in the second quarter. Jennison Associates LLC now owns 11,650 shares of the medical equipment provider’s stock valued at $1,062,000 after buying an additional 6,137 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of Masimo Corporation by 114.7% in the second quarter. BNP Paribas Arbitrage SA now owns 32,879 shares of the medical equipment provider’s stock valued at $2,998,000 after buying an additional 17,565 shares in the last quarter. Finally, Comerica Bank boosted its position in shares of Masimo Corporation by 1.1% in the second quarter. Comerica Bank now owns 35,346 shares of the medical equipment provider’s stock valued at $3,477,000 after buying an additional 395 shares in the last quarter. 84.61% of the stock is owned by institutional investors.
In other Masimo Corporation news, COO Anand Sampath sold 40,000 shares of the firm’s stock in a transaction that occurred on Tuesday, July 11th. The shares were sold at an average price of $92.00, for a total value of $3,680,000.00. Following the completion of the transaction, the chief operating officer now owns 20,000 shares of the company’s stock, valued at approximately $1,840,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jon Coleman sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 20th. The shares were sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the transaction, the insider now directly owns 32,201 shares of the company’s stock, valued at approximately $3,139,597.50. The disclosure for this sale can be found here. Insiders sold a total of 115,000 shares of company stock valued at $10,773,180 in the last quarter. 16.60% of the stock is owned by insiders.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.